ANGLE

ANGLE is an England-based liquid biopsy company that develops and commercializes cancer diagnostic products for the healthcare industry.

Business Model:

Revenue: $1.1M

Employees: 51-200

Detailed ANGLE Information

Geographic Data

ANGLE  headquarters map

Address: 10 Nugent Road

City: Guildford

State: england

Zip: GU2 7AF

Country: GB

Financial Info

Stage:

post ipo equity

Raised Last:

$24M

Raised Total:

$24M

Metrics

1,609,677Website Global Rank

15,147Website Monthly Traffic

Twitter Followers

Description

ANGLE is an England-based liquid biopsy company that develops and commercializes cancer diagnostic products for the healthcare industry.

Contact Phone:

Contact Email:

ANGLE went public on 11/9/2016 on the London Stock Exchange

Listed Exchange:
London Stock Exchange

IPO Date:
11/9/2016

Ticker Symbol:
AGL

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2015 Venture Round $250k
7/2022 Post-IPO Equity $23.9M
12/2015 Unattributed $1M
6/2021 Post-IPO Equity $27.7M
Announced Date Name Price
11/2017 Axela, Inc

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research